Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × Interleukin-2 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 18 Neoplasm Metastasis 8 Ovarian Neoplasms 7 Lymphoma, Non-Hodgkin 7 Colorectal Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Uveal Melanoma 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Recurrence 3 Multiple Myeloma 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Leukemia 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Mesothelioma, Malignant 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2

Interventions

Proton Therapy 3 pembrolizumab 2 toripalimab 1 spartalizumab 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 leronlimab 1 Valganciclovir 1 Radiotherapy 1 Paclitaxel 1 Lacteol 1 Interleukin-2 1 Docetaxel 1 Carboplatin 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05307874 2025-12-24

EVICTION-2

ImCheck Therapeutics

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡